Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Samsun
Clinical trial register · Turkey

Clinical Trials in Samsun, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Ankara 91 Istanbul 69 Adana 42 Izmir 32 Bornova 20
Narrow the registerReset
Recruitment status
Phase
Site location
Ankara91 Istanbul69 Adana42 Izmir32 Bornova20
All 43 locations
Target enrolment
to

Trials with a site in Samsun

19 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
960
Ankara, Istanbul, Samsun
2026-06-22
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC
Phase 1/2
280
Ankara, Antalya, Istanbul, Samsun
2026-05-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Adana, Ankara, Diyarbakır, Istanbul, Mersin, Rize, Samsun
2025-07-21
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC
Phase 3
2,400
Sıhhiye, Adana, Ankara, Istanbul, Kayseri, Mersin, Samsun
2025-06-30
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Adana, Ankara, Antalya, Izmir, Samsun
2025-03-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Bornova, Adana, Ankara, Istanbul, Sakarya, Samsun
2025-03-16
Active, closed
Merck Sharp & Dohme LLC
Phase 2
66
Ankara, Samsun
2024-10-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Samsun
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Adana, Ankara, Istanbul, Samsun
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Stanbul, Ankara, Izmir, Kayseri, Mersin, Samsun
2024-06-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Adana, Ankara, Diyarbakır, Erzurum, Istanbul, Samsun, Van
2024-05-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Adana, Ankara, Istanbul, Samsun
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Mersin, Samsun
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Adana, Ankara, Istanbul, Izmir, Samsun
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Ankara, Antalya, Edirne, Istanbul, Izmir, Samsun
2023-12-13
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Merck Sharp & Dohme LLC
Phase 2
189
Stanbul, Bornova, Ankara, Edirne, Samsun
2022-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Yenimahalle, Bornova, Ankara, Istanbul, Izmir, Samsun
2022-01-14
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/samsun

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Samsun that also match the filters currently applied.

How many clinical trials are recruiting in Samsun?

13 of the 19 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Samsun), 19 studies
PhaseStudiesRecruitingShare
Phase 3131068.4%
Phase 23015.8%
Phase 2/32210.5%
Phase 1/2115.3%

Most active sponsors

Lead sponsors with the most studies (Samsun)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC1913
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.